Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma

[1]  R. Claus,et al.  Impact of age and gender on lymphocyte subset counts in patients with COVID‐19 , 2021, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[2]  R. Claus,et al.  Sustained cellular immunity in adults recovered from mild COVID‐19 , 2021, Cytometry Part A.

[3]  J. Yearley,et al.  Immune phenotype of patients with stage IV metastatic inflammatory breast cancer , 2020, Breast cancer research : BCR.

[4]  C. Nicolazzo,et al.  Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights , 2020, Oncology.

[5]  M. Shimada,et al.  Impact of sidedness of colorectal cancer on tumor immunity , 2020, PloS one.

[6]  P. Dzięgiel,et al.  Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance , 2020, Cellular Oncology.

[7]  C. Verschoor,et al.  Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer , 2020, Frontiers in Immunology.

[8]  Lianhong Li,et al.  PD-1/PD-L1 pathway: current researches in cancer. , 2020, American journal of cancer research.

[9]  T. Schumacher,et al.  CD8+ T cell states in human cancer: insights from single-cell analysis , 2020, Nature Reviews Cancer.

[10]  M. Trepel,et al.  Chemotherapy markedly reduces B cells but not T cells and NK cells in patients with cancer , 2020, Cancer Immunology, Immunotherapy.

[11]  Ruizhu Zheng,et al.  Correlations between microsatellite instability and the biological behaviour of tumours , 2019, Journal of Cancer Research and Clinical Oncology.

[12]  Shaohua Chen,et al.  Age related human T cell subset evolution and senescence , 2019, Immunity & Ageing.

[13]  J. Banchereau,et al.  Sexual-dimorphism in human immune system aging , 2019, Nature Communications.

[14]  P. Kuppen,et al.  Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile , 2019, Cancer Immunology, Immunotherapy.

[15]  J. Blay,et al.  Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines? , 2019, Journal of Immunotherapy for Cancer.

[16]  P. Validire,et al.  The clinical role of the TME in solid cancer , 2018, British Journal of Cancer.

[17]  P. Dundr,et al.  Immunological examination of peripheral blood in patients with colorectal cancer compared to healthy controls , 2018, Immunological investigations.

[18]  Su Jin Lee,et al.  Diagnostic value of peripheral blood immune profiling in colorectal cancer , 2018, Annals of surgical treatment and research.

[19]  N. Kim,et al.  Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype , 2018, Expert review of anticancer therapy.

[20]  F. Chang,et al.  Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy , 2017, Applied immunohistochemistry & molecular morphology : AIMM.

[21]  M. Carolan,et al.  Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients , 2017, BMC Cancer.

[22]  K. Søreide,et al.  Correlation of Blood T-Cells to Intratumoural Density and Location of CD3+ and CD8+ T-Cells in Colorectal Cancer. , 2017, Anticancer research.

[23]  James A. Hutchinson,et al.  Age and gender leucocytes variances and references values generated using the standardized ONE‐Study protocol , 2016, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[24]  R. Greil,et al.  Cytomegalovirus reactivation and its clinical impact in patients with solid tumors , 2015, Infectious Agents and Cancer.

[25]  R. DuBois,et al.  Immunosuppression associated with chronic inflammation in the tumor microenvironment. , 2015, Carcinogenesis.

[26]  A. Toubert,et al.  Phenotypic analysis of T cells infiltrating colon cancers: Correlations with oncogenetic status , 2015, Oncoimmunology.

[27]  Li-hua Sun,et al.  Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[28]  J. Mayans,et al.  Values for αβ and γδ T‐lymphocytes and CD4+, CD8+, and CD56+ subsets in healthy adult subjects: Assessment by age and gender , 2012, Cytometry. Part B, Clinical cytometry.

[29]  G. Thibault,et al.  Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy , 2011, Cancer Chemotherapy and Pharmacology.

[30]  Matej Horvat,et al.  Microsatellite instability in colorectal cancer , 2011, Radiology and oncology.

[31]  Shuji Ogino,et al.  Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review , 2010, The Journal of pathology.

[32]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[33]  M. Kloor,et al.  Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases , 2005, British Journal of Cancer.

[34]  P. Morel,et al.  Two colons‐two cancers: Paradigm shift and clinical implications , 2004, Journal of surgical oncology.

[35]  T. Smyrk,et al.  Tumor‐infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma , 2001, Cancer.

[36]  C. S. Lee.  Lymphocytes and their subsets in the peripheral blood of hepatocellular carcinoma patients. , 1991, Journal of the Formosan Medical Association = Taiwan yi zhi.